Cargando…

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB

Medroxyprogesterone acetate (MPA) is the main conservative treatment for endometrial cancer (EC) patients desirable to preserve fertility and those who cannot suffer from surgery. Considering the high incidence of progestin resistance and recurrence of MPA treatment, we reproposed antipsychotics chl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yunxia, Wu, Huiwen, Yang, Linlin, Huang, Ting, Li, Jian, Gong, Xiaodi, Li, Lijuan, Sun, Xiao, Mao, Fei, Wang, Yudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087176/ https://www.ncbi.nlm.nih.gov/pubmed/33937078 http://dx.doi.org/10.3389/fonc.2021.665832

Ejemplares similares

Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer
por: Yang, Linlin, et al.
Publicado: (2020)

NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB
por: Cheng, Yali, et al.
Publicado: (2022)

Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy
por: Gong, Xiaodi, et al.
Publicado: (2021)

Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer
por: Pateetin, Prangwan, et al.
Publicado: (2021)

Author Correction: Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer
por: Pateetin, Prangwan, et al.
Publicado: (2021)

Expression of PRB, FKBP52 and HB-EGF Relating with Ultrasonic Evaluation of Endometrial Receptivity
por: Wang, Ning, et al.
Publicado: (2012)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
por: Shao, Fengping, et al.
Publicado: (2023)

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women()()
por: Heffron, Renee, et al.
Publicado: (2019)

ECT-CHLORPROMAZINE COMBINATION COMPARED WITH CHLORPROMAZINE ONLY IN SCHIZOPHRENIA1
por: Janakiramaiah, N., et al.
Publicado: (1981)

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021)

Hsa_Circ_0001860 Promotes Smad7 to Enhance MPA Resistance in Endometrial Cancer via miR-520h
por: Yuan, Shuang, et al.
Publicado: (2021)

Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis
por: Yang, Linlin, et al.
Publicado: (2021)

PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus
por: Man, Jiang-Hong, et al.
Publicado: (2006)

Loss of exosomal miR‐26a‐5p contributes to endometrial cancer lymphangiogenesis and lymphatic metastasis
por: Wang, Jing, et al.
Publicado: (2022)

FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt
por: Dong, Jing, et al.
Publicado: (2017)

Schwann Cell-Derived CCL2 Promotes the Perineural Invasion of Cervical Cancer
por: Huang, Ting, et al.
Publicado: (2020)

Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis
por: Yang, Linlin, et al.
Publicado: (2022)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1
por: Yang, Yuan, et al.
Publicado: (2017)

Chlorpromazine-induced lenticular opacity
por: Srinivasan, Kavitha, et al.
Publicado: (2020)

Proceedings of the ESO/MPA Workshop
por: Minniti, Dante, et al.
Publicado: (1996)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
por: Newtson, A.M., et al.
Publicado: (2017)

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions
por: Houshdaran, Sahar, et al.
Publicado: (2020)

Identification of Genes and Pathways Differentially Expressed in Progestin Responsive Endometrial Cancer and Hyperplasia
por: Gertz, Jay, et al.
Publicado: (2021)

Hormone Therapy Reduces Recurrence in Stage II-IV Uterine Low-Grade Endometrial Stromal Sarcomas: A Retrospective Cohort Study
por: Huang, Xiaodi, et al.
Publicado: (2022)

Genome-wide CRISPR screening reveals ADCK3 as a key regulator in sensitizing endometrial carcinoma cells to MPA therapy
por: Zhang, Zijing, et al.
Publicado: (2023)

Chlorpromazine-Induced Hyperprolactinemia on Rat’s Uterus
por: Zamani, Zahra, et al.
Publicado: (2015)

The Effect of Chlorpromazine on Vomiting Due to Veriloid
por: Isaacs, Bernard, et al.
Publicado: (1954)

Psychiatry and COVID-19: The Role of Chlorpromazine
por: Stip, Emmanuel
Publicado: (2020)

Determination of monosaccharide composition in human serum by an improved HPLC method and its application as candidate biomarkers for endometrial cancer
por: Chen, Yulong, et al.
Publicado: (2022)

Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance
por: Liu, Bing-jie, et al.
Publicado: (2020)

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis
por: Zhang, Yu-Fei, et al.
Publicado: (2023)

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist
por: duPont, Nefertiti Chianti, et al.
Publicado: (2010)

Partial ablation of endometrial glands in dogs after exposure to progestin during the neonatal period
por: Teixeira, Natália Soares, et al.
Publicado: (2018)

Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin
por: Pant, Alok, et al.
Publicado: (2012)

MPA-ESO Workshop on the First Stars
por: Weiss, A, et al.
Publicado: (2000)

Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins
por: Kulkarni, A., et al.
Publicado: (2023)

The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
por: Tsuda, H, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_hjoi5r4to2tuhv13td53mnrj3t